Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Marakovits, Joseph"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Murray, Brion W., Guo, Chuangxing, Piraino, Joseph, Westwick, John K., Zhang, Cathy, Lamerdin, Jane, Dagostino, Eleanor, Knighton, Daniel, Loi, Cho-Ming, Zager, Michael, Kraynov, Eugenia, Popoff, Ian, Christensen, James G., Martinez, Ricardo, Kephart, Susan E., Marakovits, Joseph, Karlicek, Shannon, Bergqvist, Simon, Smeal, Tod, Caskey, C. Thomas
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2010 May . 107(20), 9446-9451.
Externí odkaz:
https://www.jstor.org/stable/25681612
Autor:
Dragovich, Peter S, Webber, Stephen E, Prins, Thomas J, Zhou, Ru, Marakovits, Joseph T, Tikhe, Jayashree G, Fuhrman, Shella A, Patick, Amy K, Matthews, David A, Ford, Clifford E, Brown, Edward L, Binford, Susan L, Meador, James W, III, Ferre, Rose Ann, Worland, Stephen T
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 1999 9(15):2189-2194
Publikováno v:
Tetrahedron Letters. 52:1692-1696
Here we report mild, environmentally-friendly reaction conditions which enable the addition–elimination S N Ar reaction between weakly reactive substrates––an aminopyrrolopyrazole template and several substituted pyrimidines. The method was dev
Autor:
Todd VanArsdale, RoseAnn Ferre, David A. Matthews, Ian Popoff, Marakovits Joseph T, Brion W. Murray, Joseph Piraino, Barbara Mroczkowski, Dong Liming, Stephen Margosiak, Xinjun Hou, M. Catherine Johnson, James Arthur Thomson, Gerrit Los, Eleanor Dagostino, Chuangxing Guo, Samantha Elizabeth Greasley, Hans E. Parge
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 19:5613-5616
Pin1 is a member of the cis-trans peptidyl-prolyl isomerase family with potential anti-cancer therapeutic value. Here we report structure-based de novo design and optimization of novel Pin1 inhibitors. Without a viable lead from internal screenings,
Autor:
Guo, Chuangxing, Hou, Xinjun, Dong, Liming, Marakovits, Joseph, Greasley, Samantha, Dagostino, Eleanor, Ferre, RoseAnn, Catherine Johnson, M., Humphries, Paul S., Li, Haitao, Paderes, Genevieve D., Piraino, Joseph, Kraynov, Eugenia, Murray, Brion W.
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 1 September 2014 24(17):4187-4191
Autor:
Marakovits Joseph T, David R. Newell, Stephen E. Webber, Zdenek Hostomsky, Roger J. Griffin, Karen A. Maegley, Anne Ekker, Skalitzky Donald James, Bernard T. Golding, Robert Almassy, A. Hilary Calvert, Xiao-Hong Yu, Jianke Li, Eastman Brian Walter, Nicola J. Curtin
Publikováno v:
Journal of Medicinal Chemistry. 46:210-213
Novel tricyclic benzimidazole carboxamide poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors have been synthesized. Several compounds were found to be powerful chemopotentiators of temozolomide and topotecan in both A549 and LoVo cell lines. In vitro
Autor:
Li Haitao, Paderes Genevieve Deguzman, Brion W. Murray, Xinjun Hou, RoseAnn Ferre, Marakovits Joseph T, M. Catherine Johnson, Paul S. Humphries, Samantha Elizabeth Greasley, Eugenia Kraynov, Joseph Piraino, Dong Liming, Eleanor Dagostino, Chuangxing Guo
Publikováno v:
Bioorganicmedicinal chemistry letters. 24(17)
The design of potent Pin1 inhibitors has been challenging because its active site specifically recognizes a phospho-protein epitope. The de novo design of phosphate-based Pin1 inhibitors focusing on the phosphate recognition pocket and the successful
Autor:
Ya-Li Deng, Zhang Junhu, Martin Paul Edwards, James G. Christensen, Yang Anle, Lisa C. Guo, Brion W. Murray, Tikhe Jayashree Girish, Kephart Susan Elizabeth, Indrawan James Mcalpine, Marakovits Joseph T, Dong Liming, Li Haitao, Christine Del-Carmen, Tod Smeal, Daniel D. Knighton, Eugenia Kraynov, Paul G. Richardson, Eleanor Dagostino, Chuangxing Guo, Djamal Bouzida, Robert Steven Kania, Joseph Piraino, M. Catherine Johnson, Joseph K. T. Lee
Publikováno v:
Journal of medicinal chemistry. 55(10)
The P21-activated kinases (PAK) are emerging antitumor therapeutic targets. In this paper, we describe the discovery of potent PAK inhibitors guided by structure-based drug design. In addition, the efflux of the pyrrolopyrazole series was effectively
Autor:
Tod Smeal, Karlicek Shannon Marie, Kephart Susan Elizabeth, Jane Lamerdin, Marakovits Joseph T, Eleanor Dagostino, Chuangxing Guo, Joseph Piraino, John Westwick, Michael Zager, Daniel R. Knighton, Simon Bergqvist, Brion W. Murray, James G. Christensen, Cho-Ming Loi, Ricardo Martinez, Cathy Zhang, Eugenia Kraynov, Ian Popoff
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 107(20)
Despite abundant evidence that aberrant Rho-family GTPase activation contributes to most steps of cancer initiation and progression, there is a dearth of inhibitors of their effectors (e.g., p21-activated kinases). Through high-throughput screening a